BioSpace News Archive

BioCapital

ivWatch Continues to Expand Global Patent Portfolio

ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, received two patents granted by the European and Japanese Patent Offices expanding their intellectual property (IP) portfolio.

October 2, 2018
·
2 min read
Business

Fighting depression, discovering resilience and lifestyles this month on Ismael Cala’s podcast, dMENTE Positivo

Ismael Cala, life and business strategist, lecturer and author of eight bestsellers on themes of leadership and emotional intelligence, is presenting four new programs in October on his podcast dMENTE Positivo, a space about awakening awareness and personal growth.

October 2, 2018
·
2 min read
Drug Development

Results from Two Phase 3 Studies Show Lilly’s Ultra Rapid Lispro (URLi) Met Primary Efficacy Endpoint in People with Type 1 and Type 2 Diabetes

Both studies also showed greater reductions in glucose excursions after mealtime

October 2, 2018
·
9 min read
BioCapital

Tauri Group Awarded $69.7M Army Medical Contract

The Tauri Group Inc. was recently awarded a contract supporting United States Army Medical Materiel Agency (USAMMA) with a ceiling value of nearly $70 million.

October 2, 2018
·
1 min read
Business

Kurin, Inc. Announces Agreement with Premier for Kurin Lock® to Help Impact Contaminated Blood Cultures

Kurin Inc. announced today that it has been awarded a Med/Surg Group agreement in the Safety Phlebotomy Category with Premier.

October 2, 2018
·
1 min read
Drug Development

Clementia Initiates Phase 1 Clinical Trial of Palovarotene Eye Drop Formulation in Healthy VolunteersData from Study Expected in Q1 2019

Clementia Pharmaceuticals Inc. today announced the initiation of a Phase 1 clinical trial evaluating an eye drop formulation of palovarotene in healthy volunteers.

October 2, 2018
·
3 min read
Pharm Country

Amicus Therapeutics Announces Presentation and Poster at the 23rd International Congress of the World Muscle Society

Amicus Therapeutics today announced that an oral presentation and a poster highlighting its development program AT-GAA for Pompe disease will be included at the 23rd International Congress of the World Muscle Society, to be held October 2-6, 2018 in Mendoza, Argentina.

October 2, 2018
·
2 min read
Drug Development

Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On Bryhali™* (Halobetasol Propionate) Lotion, 0.01% In The Journal Of Drugs In Dermatology

Two Pivotal Trials Demonstrate the Efficacy of Investigational Drug BRYHALI Lotion Over Vehicle at Eight Weeks of Treatment, with Favorable Tolerability Profile

October 2, 2018
·
7 min read
Business

Clarkston Consulting and 4G Clinical Form New Partnership to Advance Clinical Trial Operations

Partnership to enhance value in clinical trial strategy and operations for their respective clients in the pharmaceutical and biotech industries.

October 2, 2018
·
2 min read
BioMidwest

Exicure Presents First Data Demonstrating Both Oral Delivery and Liver Delivery of Spherical Nucleic Acid Constructs in Animal Models

Two posters presented at the 14th Annual Meeting of the Oligonucleotide Therapeutics Society in Seattle, Washington

October 2, 2018
·
4 min read